CIK 0001314052 · Large accelerated filer<br>Smaller reporting company
ANAVEX LIFE SCIENCES CORP.
Sign in to watch- Ticker
- AVXL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Entity type
- operating
- EIN
- 980608404
- Phone
- 844-689-3939
- Business address
- 630 5TH AVENUE, 20TH FLOOR, NEW YORK, NY, 10111
- Former names
- Thrifty Printing Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-27 | Thomas Steffen Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-06-27 | Donhauser Peter D.O. Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-06-27 | Skarpelos Athanasios Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-06-27 | Ma Jiong Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2022-05-25 | Skarpelos Athanasios Director | Option exercise | +50,000 | $0.92 | $46K | 1,356,458 |
| 2022-05-25 | Skarpelos Athanasios Director | Sale | −50,000 | $9.06 | $453K | 1,306,458 |
| 2022-05-25 | Skarpelos Athanasios Director | Option exercise · Stock Option (Right to Buy) | +50,000 | 0 | ||
| 2021-08-02 | Ma Jiong Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2021-08-02 | Velden Claus Vander Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2021-08-02 | Boenisch Sandra PFO and Treasurer | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2021-08-02 | Donhauser Peter D.O. Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2021-08-02 | Thomas Steffen Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2021-08-02 | Skarpelos Athanasios Director | Grant or award · Stock Option (Right to Buy) | +25,000 | 25,000 | ||
| 2021-08-02 | MISSLING CHRISTOPHER U Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2021-06-29 | MISSLING CHRISTOPHER U President and CEO | Option exercise | +51,620 | $1.32 | $68K | 1,069,830 |
| 2021-06-29 | MISSLING CHRISTOPHER U President and CEO | Sale | −51,620 | $26.00 | $1.3M | 1,018,210 |
| 2021-06-29 | MISSLING CHRISTOPHER U President and CEO | Option exercise · Stock Option (Right to Buy) | −51,620 | 73,380 | ||
| 2021-06-29 | Boenisch Sandra PFO and Treasurer | Option exercise | +25,000 | $5.68 | $142K | 47,963 |
| 2021-06-29 | Boenisch Sandra PFO and Treasurer | Option exercise | +106,696 | $3.28 | $350K | 154,659 |
| 2021-06-29 | Boenisch Sandra PFO and Treasurer | Option exercise | +35,000 | $5.92 | $207K | 189,659 |
Page 4 of 12 · 232 trades